BBI offers scalable production models to fit your needs
In vitro Antibody Production in Hollow Fibre
For customers who require larger than 1 gram lot sizes and predictable yields, BBI now offers cGMP* in vitro antibody
productions in a hollow fibre continuous perfusion system, significantly improving scalability and security in bulk.
Why hollow fibre production with BBI?
+ Batch sizes up to 5 grams
+ Serum and animal component-free culture system • No contaminating mouse or bovine IgG
+ Predictable long-term costs and ability for guaranteed yields
+ Extensive expertise and capabilities in the maintenance of hybridoma cell lines, including routine subcloning
+ Protein A purification for highly pure monomeric antibody
+ Option to conjugate bulk productions to BBI’s gold nanoparticles, or seamlessly integrate with our lateral flow services
There are 3 production models to fit your requirements:
+ Evaluate productivity of cell line in hollow fibre via 4 week production run
+ 200-400mgs of cGMP* antibody
+ Post pilot, cell lines are eligible for fixed cost model
Fixed Cost Model:
+ Generate defined mass of purified monoclonal antibody
+ Defined monoclonal antibody quantity delivered at a fixed per/mg price
Run Time Model:
+ If defined yield or fixed pricing not required, run a production for a defined number of weeks in a time billing model
+ All purified antibody generated in the time scale is delivered at the close of production run
Ask us a Question:
Discuss production requirements with our team on (+1) 207-797-5454 or firstname.lastname@example.org or register your interest by completing the form.
*21 CFR Part 820, For Research and In Vitro Diagnostic Use Only